EGFR-targeted treatments in patients with metastatic colorectal cancer: Experience of panitumumab.

被引：0
|
作者：
Gumus, Mahmut
Geredeli, Caglayan
Ucar, Mahmut
Kaya, Serap
Demir, Hacer
Unal, Olcun Umit
Degirmenci, Mustafa
Dogu, Gamze Gokoz
Turan, Nedim
Yildirim, Nilgun
Basal, Fatma Bugdayci
Arpaci, Erkan
Karaagac, Mustafa
Harputluoglu, Hakan
Turk, Had Mehmet
Dane, Faysal
Ozkan, Metin
机构：
[1] Istanbul Medeniyet Univ Hosp, Dept Med Oncol, Istanbul, Turkey
[2] Okmeydani Training & Res Hosp, Dept Med Oncol, Istanbul, Turkey
[3] Erciyes Univ, Dept Med Oncol, Kayseri, Turkey
[4] Marmara Univ, Med Oncol, Istanbul, Turkey
[5] Gazi Univ, Fac Med, Med Oncol Clin, Ankara, Turkey
[6] Ataturk Training & Res Hosp, Izmir, Turkey
[7] Tepecik Educ & Res Hosp, Izmir, Turkey
[8] Pamukkale Univ, Denizli, Turkey
[9] Cumhuriyet Univ, Sch Med, Dept Med Oncol, Sivas, Turkey
[10] Ataturk Univ, Dept Med Oncol, Erzurum, Turkey
[11] Ankara Numone Training & Res Hosp, Dept Med Oncol, Ankara, Turkey
[12] Bulent Ecevit Univ, Zonguldak, Turkey
[13] Konya Necmeddin Erbakan Univ, Meram Sch Med, Diyarbakir, Turkey
[14] Inonu Univ, Dept Med Oncol, Fac Med, Malatya, Turkey
[15] Bezmialem Univ, Med Oncol, Istanbul, Turkey
[16] Erciyes Univ, Dept Med Oncol, Kayseri, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15028
引用
下载
收藏
页数：6
相关论文
共 50 条
  • [1] EGFR-Targeted therapies in colorectal cancer
    Overman, Michael J.
    Hoff, Paulo M.
    DISEASES OF THE COLON & RECTUM, 2007, 50 (08) : 1259 - 1270
  • [2] Drug insight: panitumumab, a human EGFR-targeted monoclonal antibody with promising clinical activity in colorectal cancer
    Mano, Max
    Humblet, Yves
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (07): : 415 - 425
  • [3] Drug Insight: panitumumab, a human EGFR-targeted monoclonal antibody with promising clinical activity in colorectal cancer
    Max Mano
    Yves Humblet
    Nature Clinical Practice Oncology, 2008, 5 : 415 - 425
  • [4] Novel Somatic Genetic Variants as Predictors of Resistance to EGFR-Targeted Therapies in Metastatic Colorectal Cancer Patients
    Riera, Pau
    Rodriguez-Santiago, Benjamin
    Lasa, Adriana
    Gonzalez-Quereda, Lidia
    Martin, Berta
    Salazar, Juliana
    Sebio, Ana
    Virgili, Anna C.
    Minguillon, Jordi
    Camps, Cristina
    Surralles, Jordi
    Paez, David
    CANCERS, 2020, 12 (08) : 1 - 15
  • [5] Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in patients with metastatic colorectal cancer
    C Mao
    R-Y Liao
    Q Chen
    British Journal of Cancer, 2010, 102 : 940 - 940
  • [6] Novel somatic genetic variants as predictors of resistance to EGFR-targeted therapies in metastatic colorectal cancer patients
    Riera, P.
    Rodriguez-Santiago, B.
    Lasa, A.
    Gonzalez-Quereda, L.
    Martin, B.
    Salazar, J.
    Sebio Garcia, A.
    Virgili Manrique, A. C.
    Surralles, J.
    Paez, D.
    ANNALS OF ONCOLOGY, 2020, 31 : S434 - S434
  • [7] Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in patients with metastatic colorectal cancer
    Mao, C.
    Liao, R-Y
    Chen, Q.
    BRITISH JOURNAL OF CANCER, 2010, 102 (05) : 940 - 940
  • [8] Acquired resistance to EGFR-targeted therapies in colorectal cancer
    Van Emburgh, Beth O.
    Sartore-Bianchi, Andrea
    Di Nicolantonio, Federica
    Siena, Salvatore
    Bardelli, Alberto
    MOLECULAR ONCOLOGY, 2014, 8 (06) : 1084 - 1094
  • [9] Colorectal adenocarcinoma-derived EGFR mutants are oncogenic and sensitive to EGFR-targeted monoclonal antibodies, cetuximab and panitumumab
    Kim, Nayoung
    Cho, Daseul
    Kim, Hyunjin
    Kim, Sujin
    Cha, Young-je
    Greulich, Heidi
    Bass, Adam
    Cho, Hyun-Soo
    Cho, Jeonghee
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (08) : 2194 - 2200
  • [10] HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer
    Sartore-Bianchi, Andrea
    Amatu, Alessio
    Porcu, Luca
    Ghezzi, Silvia
    Lonardi, Sara
    Leone, Francesco
    Bergamo, Francesca
    Fenocchio, Elisabetta
    Martinelli, Erika
    Borelli, Beatrice
    Tosi, Federica
    Racca, Patrizia
    Valtorta, Emanuele
    Bonoldi, Emanuela
    Martino, Cosimo
    Vaghi, Caterina
    Marrapese, Giovanna
    Ciardiello, Fortunato
    Zagonel, Vittorina
    Bardelli, Alberto
    Trusolino, Livio
    Torri, Valter
    Marsoni, Silvia
    Siena, Salvatore
    ONCOLOGIST, 2019, 24 (10): : 1395 - 1402
12345